TH.TO
Theratechnologies Inc
Price:  
4.57 
CAD
Volume:  
62,204.00
Canada | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TH.TO WACC - Weighted Average Cost of Capital

The WACC of Theratechnologies Inc (TH.TO) is 9.2%.

The Cost of Equity of Theratechnologies Inc (TH.TO) is 8.10%.
The Cost of Debt of Theratechnologies Inc (TH.TO) is 12.95%.

Range Selected
Cost of equity 7.10% - 9.10% 8.10%
Tax rate 0.60% - 1.30% 0.95%
Cost of debt 11.00% - 14.90% 12.95%
WACC 7.9% - 10.4% 9.2%
WACC

TH.TO WACC calculation

Category Low High
Long-term bond rate 3.2% 3.7%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.76 0.81
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.10% 9.10%
Tax rate 0.60% 1.30%
Debt/Equity ratio 0.3 0.3
Cost of debt 11.00% 14.90%
After-tax WACC 7.9% 10.4%
Selected WACC 9.2%

TH.TO's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for TH.TO:

cost_of_equity (8.10%) = risk_free_rate (3.45%) + equity_risk_premium (5.60%) * adjusted_beta (0.76) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.